Back on TRAC: New trial launched in bid to outpace multidrug-resistant malaria-Reference-Cited by-同舟云学术

Back on TRAC: New trial launched in bid to outpace multidrug-resistant malaria

Published:2016-03 Issue:3 Volume:22 Page:220-221
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Maxmen Amy

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm0316-220.pdf

Reference7 articles.

1. Amaratunga, C. et al. Lancet Infect Dis., doi:10.1016/S1473-3099(15)00487-9 (2016).

2. Ashley, E.A. et al. N. Eng. J. Med. 371, 411–423 (2014).

3. World Health Organization. World Malaria Report 2015. http://apps.who.int/iris/bitstream/10665/200018/1/9789241565158_eng.pdf?ua=1 (2015).

4. Garcia, R., Hewitt, S. & Tulloch, J. Report of the mid-term review of the Global Fund Regional Artemisinin Initiative (RAI). 1–67 (Global Fund, 2015).

5. Ariey, F. et al. Nature 505, 50–55 (2014).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum;Malaria Journal;2020-05-13

2. New derivatives of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities;Monatshefte für Chemie - Chemical Monthly;2019-10-23

3. Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum;2019-05-31

4. OUP accepted manuscript;Journal of Travel Medicine;2019

5. The antimalarial pipeline;Current Opinion in Pharmacology;2018-10